Analyzing CME Group’s (CME) Stock Performance Amidst Market Volatility

In the second quarter of 2026, Baron Financials ETF (the Fund) saw a 1.82% increase in value, trailing both the MSCI USA Financials Index (up 8.93%) and the FactSet Global FinTech Index (up 6.14%). The U.S. equities market experienced significant gains, primarily fueled by investments in AI infrastructure, despite facing challenges from the U.S.-Iran conflict, changing Federal Reserve policies, and rising consumer costs due to inflation.

The majority of these gains were derived from the Information Technology and Industrials sectors, with IT leading the growth at 31.8%.

While growth sectors outperformed value sectors in the quarter, value stocks still led the year-to-date performance. Small-cap stocks outperformed their large-cap counterparts. Baron Financials ETF's underperformance relative to the Financials Index can be attributed to its reduced exposure to banks and a higher allocation to software and data firms adversely affected by AI disruption fears.

The Fund remains optimistic about the holdings in its portfolio, believing they are undervalued, and maintains a positive outlook despite the current economic climate featuring robust consumer and business spending. Baron Financials ETF disclosed that CME Group Inc. (NASDAQ:CME) underperformed within the Fund this quarter. CME Group Inc. (NASDAQ:CME), a prominent financial derivatives marketplace operator focusing on futures and options products, experienced a share price decline on August 27, 2026, closing at $280.94.

The stock showed a 6.04% return over the past month and a 6.55% gain over the last 52 weeks. The company's market capitalization stands at $101.02 billion.

Baron Financials ETF explained that CME Group Inc.'s shares fell due to a slowdown in trading activity, reflecting unfavorable comparisons to the previous year's tariff-driven uncertainty and decreased market volatility following the deescalation of the U.S.-Iran conflict. This slowdown was further compounded by apprehensions about emerging competition from crypto-native perpetual futures markets and uncertainty surrounding the impending departure of long-time CEO Terry Duffy next year.

The Fund believes the recent sell-off is exaggerated and holds minimal risk to CME Group's dominant institutional franchise. They continue to hold the stock, confident in its competitive advantages and the potential benefits from the increasing adoption of exchange-traded derivatives and periodic market volatility spikes.

Despite CME Group Inc. (NASDAQ:CME) not being among the 40 most popular stocks among hedge funds, 88 hedge fund portfolios held the stock at the end of the second quarter, up from 70 in the previous quarter. While the Fund acknowledges CME Group's potential, they believe certain AI stocks offer greater upside and carry less downside risk. The Fund suggests exploring their free report on the best short-term AI stock for an undervalued investment opportunity.

In another article, the Fund discussed CME Group Inc. (NASDAQ:CME) and presented a list of oversold, strong buy-rated stocks to consider for investment. CME Group Inc. (NASDAQ:CME) demonstrated strength in Q1 2026, driven by higher trading volumes during a period of elevated market volatility. Readers are encouraged to explore the Fund's Q2 2026 investor letters on their website for additional insights from leading investors.